-Reuters
Medtronic’s EV ICD System Proves Effective in Cardiac Arrhythmia Management: Long-term Study Results
Medtronic plc (NYSE: MDT) announced longer-term follow-up results of its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) System, designed to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest, including patients followed